Sedative use in the last week of life and the implications for end-of-life decision making

Archives of Internal Medicine

Volumn 163, Issue 3, 2003, Pages 341-344

  Sykes, Nigel ^a,b   Thorns, Andrew ^a,b  

^a ST CHRISTOPHER S HOSPICE   (United Kingdom)

^b National Health Service Trust   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BENZODIAZEPINE DERIVATIVE; HALOPERIDOL; LEVOMEPROMAZINE; MIDAZOLAM; PHENOBARBITAL; PROPOFOL; SEDATIVE AGENT;

AGED; AGITATION; ARTICLE; DECISION MAKING; DOSE RESPONSE; DRUG INDICATION; DRUG SAFETY; DRUG USE; DYING; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL ETHICS; PALLIATIVE THERAPY; PRESCRIPTION; PRIORITY JOURNAL; RISK BENEFIT ANALYSIS; SEDATION; SURVIVAL; TERMINAL DISEASE; TIME SERIES ANALYSIS;

DEATH AND EUTHANASIA; EMPIRICAL APPROACH; PROFESSIONAL PATIENT RELATIONSHIP;

ADULT; AGED; ANTICONVULSANTS; DECISION MAKING; DELIRIUM; DOUBLE EFFECT; ETHICS, CLINICAL; ETHICS, MEDICAL; FEMALE; HUMANS; HYPNOTICS AND SEDATIVES; MALE; METHOTRIMEPRAZINE; MIDAZOLAM; MIDDLE AGED; PALLIATIVE CARE; PHENOBARBITAL; PROPOFOL; STATUS EPILEPTICUS; SURVIVAL ANALYSIS; TERMINAL CARE; TIME FACTORS; UNITED STATES;

EID: 0037429114     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.163.3.341     Document Type: Article

References (13)

1. Ventafridda V, Ripamonti C, De Conno F, Tamburini M, Cassileth BR. Symptom prevalence and control during cancer patients' last days of life. J Palliat Care. 1990;6(3):7-11.
2. Stone P, Phillips C, Spruyt O, Waight C. A comparison of the use of sedatives in a hospital support team and in a hospice. Palliat Med. 1997;11:140-144.
3. Fainsinger RL, Waller A, Bercovici M, et al. A multicentre international study of sedation for uncontrolled symptoms in terminally ill patients. Palliat Med. 2000;14:257-265.
4. Billings JA, Block SD. Slow euthanasia. J Palliat Care. 1996;12(4):21-30.
5. Latimer EJ. Ethical decision-making in the care of the dying and its applications to clinical practice. J Pain Symptom Manage. 1991;6:329-336.
6. Quill TE. The ambiguity of clinical intentions. N Engl J Med. 1993;329:1039-1040.
7. Thorns A, Sykes NP. Opioid use in the last week of life and the implications for end of life decision-making. Lancet. 2000;356:398-399.
8. Wyant M, Diamond BI, O'Neal E, Sloan A, Borison RL. The use of midazolam in acutely agitated psychiatric patients. Psychopharmacol Bull. 1990;26:126-129.
9. Blin O, Azorin JM, Bouhours P. Antipsychotic and anxiolytic properties of risperidone, haloperidol and methotrimeprazine in schizophrenic patients. J Clin Psychopharmacol. 1996;16:38-44.
10. Morita T, Tsunod J, Inoue S, Chihara S. Do hospice clinicians sedate patients intending to hasten death? J Palliat Care. 1999;15(3):20-23.
11. Chiu TY, Hu WY, Lue BH, Cheng SY, Chen CY. Sedation for refractory symptoms of terminal cancer patients in Taiwan. J Pain Symptom Manage. 2001;21:467-472.
12. Cole MG, Primeau F. Prognosis of delirium in elderly hospital patients. CMAJ. 1993;149:41-46.
13. Sirois F. Psychosis as a mode of exitus in a cancer patient. J Palliat Care. 1993; 9(4):16-18.